Literature DB >> 3976675

Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic.

S M Garabedian-Ruffalo, D R Gray, M J Sax, R L Ruffalo.   

Abstract

The effectiveness of a pharmacist-managed warfarin anticoagulation clinic in maintaining therapeutic prothrombin times and preventing hospitalizations secondary to inadequate control of anticoagulation was evaluated. Patients who had received warfarin sodium for at least one year before being referred to the anticoagulation clinic were studied using retrospective chart reviews. Clinical pharmacists provided patient education, monitored patients for hemorrhagic and thromboembolic complications, and adjusted warfarin sodium dosage to maintain therapeutic prothrombin times. The patients' primary physicians retained responsibility for overall care and were consulted by pharmacists regarding complications of anticoagulation and patient unreliability. The percentage of patients requiring hospitalization (39% versus 4%) and the percentage of prothrombin times outside the therapeutic range (35.8% versus 14.4%) were significantly higher during the preclinic phase (before referral to the clinic) than during the clinic phase. Eight patients were hospitalized for hemorrhagic complications and four for thromboembolism during the preclinic phase; only one hospitalization for hemorrhage occurred during the clinic phase. The warfarin anticoagulation clinic staffed by specially trained pharmacists provided improved therapy compared with treatment received by patients before their referral to the clinic.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976675

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  17 in total

1.  Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-01       Impact factor: 2.300

2.  Development and implementation of a pharmacist-managed inpatient warfarin protocol.

Authors:  David L Damaske; Robert W Baird
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

3.  Inpatient Oral Anticoagulation Management by Clinical Pharmacists: Safety and Cost effectiveness.

Authors:  Sharath R Hosmane; Johanna Tucker; Dave Osman; Steve Williams; Paul Waterworth
Journal:  J Clin Med Res       Date:  2010-03-31

4.  Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes.

Authors:  Laura G Stoudenmire; Christina E DeRemer; Hazem Elewa
Journal:  Int J Hematol       Date:  2014-06-21       Impact factor: 2.490

5.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

6.  Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.

Authors:  Fredric W H Chan; Raymond S M Wong; Wing-Hung Lau; Thomas Y K Chan; Gregory Cheng; Joyce H S You
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

7.  A computerized intervention to improve timing of outpatient follow-up: a multicenter randomized trial in patients treated with warfarin. National Consortium of Anticoagulation Clinics.

Authors:  S D Fihn; M B McDonell; D Vermes; J G Henikoff; D C Martin; C M Callahan; D L Kent; R H White
Journal:  J Gen Intern Med       Date:  1994-03       Impact factor: 5.128

8.  Evaluation of warfarin dosing by pharmacists for elderly medical in-patients.

Authors:  Naomi Burns
Journal:  Pharm World Sci       Date:  2004-08

Review 9.  The future of anticoagulation clinics.

Authors:  Edith A Nutescu
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

Review 10.  The decision to anticoagulate: assessing whether benefits outweigh the risks for patients with atrial fibrillation.

Authors:  Geno Merli; Howard H Weitz
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.